Autres langues RaQualia Pharma Inc.

Actions

4579

JP3967150008

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 05/07/2024			Varia. 5j.	Varia. 1 janv.
594 ^JPY	+1,02%		0,00%	-13,66%

26/03	RaQualia Pharma Inc. (TSE:4579) a conclu l'acquisition de FIMECS, Inc. auprès de Yusuke Tominari, Kamakanae, Nissay Capital No. 11 Investment Limited Partnership géré par Nissay Capital Co., Ltd, ANRI No. 4 Fund géré par ANRI et d'autres.	CI
14/02	RaQualia Pharma Inc. fournit des prévisions de résultats consolidés pour l'exercice se terminant le 31 décembre 2024	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

RaQualia Pharma Inc. completed the acquisition of FIMECS, Inc. from Yusuke Tominari, Kamakanae, Nissay Capital No. 11 Investment Limited Partnership managed by Nissay Capital Co., Ltd., ANRI No. 4 Fund managed by ANRI and others.	26/03
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024	14/02
RaQualia Pharma Inc. agreed to acquire FIMECS, Inc. from Nissay Capital No. 11 Investment Limited Partnership and Nissay Capital Co., Ltd. for ¥4.5 billion.	14/02
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023	10/08/23
Constipation Pipeline, Clinical Trials, and Key Companies\|Companies-Anji Pharma, Yuhan, Theravance Biopharma	12/06/23
RaQualia Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023	15/05/23
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023	14/02/23
RaQualia Pharma Inc. announced that it has received ¥805.6125 million in funding from CVI Investments, Inc.	05/01/23
RaQualia Pharma Inc. announced that it expects to receive Ã‘805.6125 million in funding from CVI Investments, Inc.	20/12/22
Raqualia Pharma Inc. Provides Consolidated Earnings Guidance for Year Ending December 31, 2022	11/11/22
RaQualia Pharma : Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending December 31, 2022 (JGAAP)	15/08/22
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022	15/08/22
RaQualia Pharma : (Delayed)Summary of Consolidated Financial Results for the Fiscal Year Ended December 31, 2021 (JGAAP)	15/02/22
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022	15/02/22
RaQualia Pharma Inc. Provides Earnings Guidance for the Year Ending December 31, 2021	12/11/21
Raqualia Pharma Inc. Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2021	12/08/21
RaQualia Pharma Inc. Announces Consolidated Financial Results for the Six Months Ended June 30, 2021	12/08/21
RaQualia Pharma Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2021	14/05/21
RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2021	14/05/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues RaQualia Pharma Inc.

Actions

4579

JP3967150008

Autres langues

Filtres